More Globe Newswire

View Older Stories View Newer Stories

Oct 15, 2024 08:00AM Sloane & Company Expands its Healthcare Practice with the Appointment of Managing Director Leslie Wheeler
Oct 15, 2024 08:00AM Blackford Capital Expands Its Patio Consolidation Platform with the Acquisition of Empire Distributing
Oct 15, 2024 08:00AM Acronis and VirtualTech Celebrate the Opening of Escuela Rural Productiva in Mexico to Empower Local Youth Through Culturally Rich Education
Oct 15, 2024 08:00AM Online Retailer Sticker Mule Moves AI Processing to the Rumble Cloud
Oct 15, 2024 08:00AM Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
Oct 15, 2024 08:00AM FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer’s Studies, Paving the Way to NDAs
Oct 15, 2024 08:00AM Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers
Oct 15, 2024 08:00AM Pineapple Energy Announces Previously Approved Reverse Stock Split, Effective October 17, 2024
Oct 15, 2024 08:00AM Provident Bank’s First-Time Home Buyer Survey Reveals That While Homeownership Continues to Be Challenging, Many Americans Are Finding Their Home in Less Than a Year
Oct 15, 2024 08:00AM Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting
Oct 15, 2024 08:00AM Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
Oct 15, 2024 08:00AM More Than One-Third of Gig Workers Rely on Gig Work as Primary Source of Income
Oct 15, 2024 08:00AM Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024
Oct 15, 2024 08:00AM atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Oct 15, 2024 08:00AM Second Gold for Regula at the Merit Awards for Cybersecurity
Oct 15, 2024 08:00AM Extendicare Announces October 2024 Dividend of C$0.04 per Share
Oct 15, 2024 08:00AM Vestaron Corporation Announces Strategic Collaboration with ADM for Production of Peptide-Based Crop Protection Products
Oct 15, 2024 08:00AM AvantGuard, a Becklar Company, Raises Funds for Families in Need
Oct 15, 2024 08:00AM WEC Energy Group Selects Lucasys Tax to Enhance Integration and Compliance Processes
Oct 15, 2024 08:00AM GLMX Reports Third Quarter 2024 Activity
Oct 15, 2024 08:00AM Talkspace to Report Third Quarter 2024 and Host Conference Call
Oct 15, 2024 08:00AM Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings
Oct 15, 2024 07:56AM Michigan Schools Gain Free Access to STEM Career Exploration Tools
Oct 15, 2024 07:54AM Nova Leap Health Corp. Announces Expansion to Florida With Execution of Definitive Agreement
Oct 15, 2024 07:50AM BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
Oct 15, 2024 07:50AM ZyVersa Therapeutics CEO, Stephen C. Glover, Was a Featured Guest on The Big Biz Show to Discuss Current Trends in the Obesity Drug Market and the Potential Role of Inflammasome Inhibitors
Oct 15, 2024 07:50AM Landstar to Release Third Quarter Results on Tuesday, October 29, 2024
Oct 15, 2024 07:45AM Trailbreaker Initiates Multiple Geophysical Surveys at the Liberty Copper-Molybdenum Project, British Columbia
Oct 15, 2024 07:41AM Swvl Launches its Regional Headquarters in Riyadh as Part of GCC Growth Strategy
Oct 15, 2024 07:35AM Rail Vision to Participate at The LD Micro Main Event XVII
Oct 15, 2024 07:30AM Palvella Therapeutics Announces Presentations at the 12th Pediatric Dermatology Research Alliance (PeDRA) Annual Conference
Oct 15, 2024 07:30AM Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
Oct 15, 2024 07:30AM Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibito
Oct 15, 2024 07:30AM Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD
Oct 15, 2024 07:30AM Watsco Schedules Third Quarter Earnings Conference Call on Wednesday, October 23, 2024
Oct 15, 2024 07:30AM Cerro de Pasco Resources Reports Initial Assay Results from its Quiulacocha Tailings Drill Campaign
Oct 15, 2024 07:30AM BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni
Oct 15, 2024 07:30AM One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry
Oct 15, 2024 07:30AM ZenaTech Announces First US Trial of the ZenaDrone IQ Nano Drone for Inventory Management by an Auto Parts Manufacturer
Oct 15, 2024 07:30AM Attovia Therapeutics Appoints Chief Financial Officer
Oct 15, 2024 07:30AM Bombardier to Report Third Quarter Financial Results on November 7, 2024
Oct 15, 2024 07:30AM Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibito
Oct 15, 2024 07:25AM Allied Announces Commitment to Set Science-Based Emissions Reduction Targets and Announces 2024 GRESB Score
Oct 15, 2024 07:19AM MRC Global Announces Actions to Strengthen Its Capital Structure
Oct 15, 2024 07:15AM CECO Environmental Upsizes Credit Facility to $400 Million
Oct 15, 2024 07:14AM MGA Entertainment and Sanrio® Partner to Create the Newest Mini Collectible Collaboration MGA's Miniverse™ Make It Mini Food™ Hello Kitty®
Oct 15, 2024 07:14AM MGA Entertainment and Sanrio® Partner to Create the Newest Mini Collectible Collaboration MGA's Miniverse™ Make It Mini Food™ Hello Kitty®
Oct 15, 2024 07:05AM Kharmagtai Maiden Ore Reserve, Updated Mineral Resource
Oct 15, 2024 07:05AM Allyx Therapeutics Awarded $3.3 Million NIH Grant to Support Further Clinical Studies of Lead Candidate ALX-001
Oct 15, 2024 07:05AM uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS
View Newer Stories View Older Stories